Want to see IL:DANE full AI Analyst Report?
Top Page
Danel
(TASE:DANE)
Select Model
Select Model
Rating:62Neutral
Price Target:
48,887.00
▲(16.90% Upside)
Action:Reiterated
Date:08/19/26
The score is driven primarily by improving financial performance (recovery in profitability, solid TTM margins, and reduced leverage), supported by an attractive dividend yield with a moderate P/E. These positives are materially offset by weak technicals (price below major moving averages and negative MACD) and ongoing concerns around cash conversion and historical cash-flow/margin volatility.
Positive Factors
Profitability Recovery
The sharp TTM revenue acceleration and recovery from the 2023 loss indicate renewed operating momentum. Solid EBITDA and operating margins provide a stronger base for funding services, supporting resilience and potential earnings compounding over the next several quarters.
Negative Factors
Margin Volatility
The multi-year decline and subsequent modest recovery in gross margin indicate that profitability has not been consistently stable. Continued cost pressure could limit the durability of current operating margins and make future earnings more sensitive to changes in service economics.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
The sharp TTM revenue acceleration and recovery from the 2023 loss indicate renewed operating momentum. Solid EBITDA and operating margins provide a stronger base for funding services, supporting resilience and potential earnings compounding over the next several quarters.
Read all positive factors
Danel (DANE) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪2.55B
Dividend Yield5.11%
Average Volume (3M)6.91K
Price to Earnings (P/E)19.5
Beta (1Y)0.83
Revenue Growth5.07%
EPS Growth504.91%
CountryIL
Employees4,288
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)22.24
Shares Outstanding5,964,349
10 Day Avg. Volume7,688
30 Day Avg. Volume6,908
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)5.35
Price to Sales (P/S)0.94
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Danel Business Overview & Revenue Model
Company Description
Operating in Israel, Danel (Adir Yeoshua) Ltd specializes in delivering a comprehensive suite of human resource solutions. The firm's core offerings encompass talent acquisition (recruitment and placement), payroll administration, and project over...
How the Company Makes Money
Danel makes money primarily by providing services under contracts and ongoing service engagements, earning revenue for delivering personnel and care rather than selling physical products. Key revenue streams generally include: (1) Home-care and nu...
Danel Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
70
Positive
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.98B | 2.90B | 2.77B | 2.51B | 2.36B | 2.29B |
| Gross Profit | 539.33M | 492.05M | 510.71M | 458.31M | 464.44M | 492.51M |
| EBITDA | 299.07M | 304.07M | 223.18M | 84.01M | 206.17M | 328.16M |
| Net Income | 130.50M | 116.95M | 20.51M | -11.22M | 115.79M | 174.15M |
Balance Sheet | ||||||
| Total Assets | 1.40B | 1.42B | 1.31B | 1.30B | 1.27B | 1.13B |
| Cash, Cash Equivalents and Short-Term Investments | 188.02M | 213.43M | 251.20M | 185.15M | 139.98M | 81.09M |
| Total Debt | 315.87M | 326.89M | 363.56M | 376.07M | 335.48M | 262.58M |
| Total Liabilities | 859.50M | 907.58M | 853.41M | 816.38M | 758.19M | 729.68M |
| Stockholders Equity | 530.80M | 507.56M | 452.26M | 471.44M | 493.17M | 364.45M |
Cash Flow | ||||||
| Free Cash Flow | 166.75M | 143.06M | 187.65M | 156.91M | 141.66M | 180.19M |
| Operating Cash Flow | 243.99M | 235.81M | 223.06M | 206.72M | 205.71M | 231.64M |
| Investing Cash Flow | -109.45M | -96.30M | -34.05M | -73.82M | -79.02M | -124.25M |
| Financing Cash Flow | -203.08M | -177.29M | -122.96M | -87.73M | -67.80M | -167.71M |
Danel Technical Analysis
Negative
41820.00
Price Trends
43011.43
Positive
43732.57
Negative
44343.59
Negative
Market Momentum
403.16
Positive
46.74
Neutral
8.65
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:DANE, the sentiment is Negative. The current price of 41820 is below the 20-day moving average (MA) of 43698.00, below the 50-day MA of 43011.43, and below the 200-day MA of 44343.59, indicating a neutral trend. The MACD of 403.16 indicates Positive momentum. The RSI at 46.74 is Neutral, neither overbought nor oversold. The STOCH value of 8.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:DANE.
Danel Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ₪1.94B | 8.00 | ― | 7.35% | 5.80% | -24.85% | |
62 Neutral | ₪2.55B | 19.46 | ― | 5.11% | 5.07% | 504.91% | |
57 Neutral | ₪2.98B | 28.23 | ― | 1.83% | 1.71% | 35.58% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ₪1.76B | 38.81 | ― | 2.83% | -11.25% | -65.58% | |
43 Neutral | ₪1.28B | -6.04 | ― | 1.75% | 5.23% | 29.87% |
* General Sector Average
IL:DANE
Danel
43,270.00
-1,298.48
-2.91%
IL:PTBL
Propert & Buil
25,570.00
-9,633.40
-27.36%
IL:AFHL
Afcon Hold
49,090.00
21,101.47
75.39%
IL:ELCRE
Electra Real E.
1,536.00
-3,102.89
-66.89%
IL:SLARL
Sella Real Est
776.00
-335.82
-30.20%
IL:ACKR
Ackerstein Grp.
611.60
-379.70
-38.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.